These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 22260506)

  • 1. Nanoparticles: a review of particle toxicology following inhalation exposure.
    Bakand S; Hayes A; Dechsakulthorn F
    Inhal Toxicol; 2012; 24(2):125-35. PubMed ID: 22260506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health effects of inhaled engineered and incidental nanoparticles.
    Madl AK; Pinkerton KE
    Crit Rev Toxicol; 2009; 39(8):629-58. PubMed ID: 19743943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fine, ultrafine and nano- particles in the living and working setting: potential health effects and measurement of inhalation exposure].
    Marconi A
    G Ital Med Lav Ergon; 2006; 28(3):258-65. PubMed ID: 17144413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of particle parameters in the evaluation of exposure-dose-response relationships of inhaled particles.
    Oberdorster G
    Inhal Toxicol; 1996; 8 Suppl():73-89. PubMed ID: 11542496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineered nanoparticle respiratory exposure and potential risks for cardiovascular toxicity: predictive tests and biomarkers.
    Simeonova PP; Erdely A
    Inhal Toxicol; 2009 Jul; 21 Suppl 1():68-73. PubMed ID: 19558236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Advances of study on inhalation toxicity of nanoparticles].
    Zhang T; Tang M
    Wei Sheng Yan Jiu; 2008 Sep; 37(5):633-6. PubMed ID: 19069671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for nanoparticle surface reactivity in facilitating pulmonary toxicity and development of a base set of hazard assays as a component of nanoparticle risk management.
    Warheit DB; Reed KL; Sayes CM
    Inhal Toxicol; 2009 Jul; 21 Suppl 1():61-7. PubMed ID: 19558235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The carcinogenic potential of nanomaterials, their release from products and options for regulating them.
    Becker H; Herzberg F; Schulte A; Kolossa-Gehring M
    Int J Hyg Environ Health; 2011 Jun; 214(3):231-8. PubMed ID: 21168363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanotechnology safety concerns revisited.
    Stern ST; McNeil SE
    Toxicol Sci; 2008 Jan; 101(1):4-21. PubMed ID: 17602205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of the in vivo and in vitro toxicity of silver and gold particulates: particle attributes and biological mechanisms responsible for the observed toxicity.
    Johnston HJ; Hutchison G; Christensen FM; Peters S; Hankin S; Stone V
    Crit Rev Toxicol; 2010 Apr; 40(4):328-46. PubMed ID: 20128631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the toxicity of selected types of nanochemicals.
    Kumar V; Kumari A; Guleria P; Yadav SK
    Rev Environ Contam Toxicol; 2012; 215():39-121. PubMed ID: 22057930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporation of particle size differences between animal studies and human workplace aerosols for deriving exposure limit values.
    Oller AR; Oberdörster G
    Regul Toxicol Pharmacol; 2010; 57(2-3):181-94. PubMed ID: 20172011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological interactions and toxicity of nanomaterials in the respiratory tract and various approaches of aerosol generation for toxicity testing.
    Creutzenberg O
    Arch Toxicol; 2012 Jul; 86(7):1117-22. PubMed ID: 22418596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Airborne engineered nanoparticles: potential risks and monitoring challenges for assessing their impacts on children.
    Biskos G; Schmidt-Ott A
    Paediatr Respir Rev; 2012 Jun; 13(2):79-83. PubMed ID: 22475252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respiratory effects of manufactured nanoparticles.
    Andujar P; Lanone S; Brochard P; Boczkowski J
    Rev Mal Respir; 2011 Oct; 28(8):e66-75. PubMed ID: 22099416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health effects related to nanoparticle exposures: environmental, health and safety considerations for assessing hazards and risks.
    Warheit DB; Sayes CM; Reed KL; Swain KA
    Pharmacol Ther; 2008 Oct; 120(1):35-42. PubMed ID: 18703086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicological perspectives of inhaled therapeutics and nanoparticles.
    Hayes AJ; Bakand S
    Expert Opin Drug Metab Toxicol; 2014 Jul; 10(7):933-47. PubMed ID: 24810077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing strategies to establish the safety of nanomaterials: conclusions of an ECETOC workshop.
    Warheit DB; Borm PJ; Hennes C; Lademann J
    Inhal Toxicol; 2007 Jun; 19(8):631-43. PubMed ID: 17510836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Particle size-dependent total mass deposition in lungs determines inhalation toxicity of cadmium chloride aerosols in rats. Application of a multiple path dosimetry model.
    Cassee FR; Muijser H; Duistermaat E; Freijer JJ; Geerse KB; Marijnissen JC; Arts JH
    Arch Toxicol; 2002 Jun; 76(5-6):277-86. PubMed ID: 12107645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary toxicity and fate of agglomerated 10 and 40 nm aluminum oxyhydroxides following 4-week inhalation exposure of rats: toxic effects are determined by agglomerated, not primary particle size.
    Pauluhn J
    Toxicol Sci; 2009 May; 109(1):152-67. PubMed ID: 19251949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.